Methods for the culture of human embryonic stem cells on human feeder cells

• US 7,432,104 B2
• Filed: 08/06/2002
• Issued: 10/07/2008
• Est. Priority Date: 08/06/2001
• Status: Expired due to Fees

• Current Assignee: Viacyte Incorporated (Vertex Pharmaceuticals Incorporated)
• Original Assignee: Bresgen Incorporated
• Inventors: Mitalipova, Maisam, Lyons, Ian
• Primary Examiner(s): Crouch; Deborah
• Application Number:
  US10/486,408
• Publication Number:
  US 20050037488A1
• Time in Patent Office: 2,254 Days
• Field of Search: 435/373, 435/375, 435/377
• US Class Current: 435/373
• CPC Class Codes: A61K 35/12 Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells vaccines or medicinal preparations containing antigens or antibodies A61K39/00
• CPC Class Codes: C12N 2501/115 Basic fibroblast growth factor (bFGF, FGF-2)
• CPC Class Codes: C12N 2501/235 Leukemia inhibitory factor [LIF]
• CPC Class Codes: C12N 2502/13 connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
• CPC Class Codes: C12N 2502/1323 Adult fibroblasts
• CPC Class Codes: C12N 2502/1335 Skeletal muscle cells, myocytes, myoblasts, myotubes
• CPC Class Codes: C12N 2502/1394 Bone marrow stromal cells; whole marrow
• CPC Class Codes: C12N 2502/243 Cells of the female genital tract, non-germinal ovarian cells
• CPC Class Codes: C12N 5/0606 Pluripotent embryonic cells, e.g. embryonic stem cells [ES] embryonic germ cells C12N5/0611, induced pluripotent stem cells C12N5/0696

Abstract

Methods and cell culture medium for the generation of human pluripotent embryonic stem cells are disclosed. Human embryonic stem cells are cultured with human granulosa feeder cells, muscle cells, Fallopian ductal epithelial cells, bone marrow stromal cells, and skin fibroblasts and the embryonic stem cells maintain their pluripotent phenotype. The human pluripotent embryonic stem cells can be cultured without feeder cells, and in the presence of supplemental growth factors. The human pluripotent embryonic stem cells can be alternatively cultured with conditioned medium obtained from a cell culture capable of maintaining human embryonic stem cells in a pluripotent state, wherein the cell culture is a human granulosa cell culture.

Claims

1. A human pluripotent stem cell culture, comprising a human embryonic stem cell and a human feeder cell, wherein the human feeder cell is selected from the group consisting of a fetal skin fibroblast cell and a skin keloid fibroblast cell, and wherein the human feeder cell maintains the human embryonic stem cell in an undifferentiated state for at least two passages.

2. The human pluripotent embryonic stem cells culture of claim 1, where the human feeder cell is a skin keloid fibroblast cell.

3. The human embryonic stem cell culture of claim 1, wherein the skin keloid fibroblast cell is ATCC deposit number CRL-1762.

4. The human pluripotent embryonic stem cells culture of claim 1, where the human feeder cell is a fetal skin fibroblast cell.

5. A method of maintaining a human embryonic stem cell culture in an undifferentiated state for at least two passages, comprising culturing a human embryonic stem cell on a human feeder cell layer, wherein the human feeder cell is selected from the group consisting of a fetal skin fibroblast cell and a skin keloid fibroblast cell.

6. The method of claim 5, wherein the human feeder cell is a skin keloid fibroblast cell.

7. The method of claim 6, wherein the skin keloid fibroblast cell is ATCC deposit number CRL-1762.

8. The human pluripotent embryonic stem cells culture of claim 5, where the human feeder cell is a fetal skin fibroblast cell.

9. A method of maintaining a human embryonic stem cell culture, comprising the steps of:

(a) isolating cells from the inner cell mass of a blastocyst;

(b) plating the inner cell mass cells, wherein inner cell mass-derived cell masses are formed; and

(c) re-plating and maintaining the human embryonic stem cell colony on a human feeder cell layer, wherein the human feeder cell is selected from the group consisting of a fetal skin fibroblast cell and a skin keloid fibroblast cell, thereby maintaining a human embryonic stem cell in an undifferentiated state for at least two passages.

10. The method of claim 9, further comprising the step of selecting a colony with the characteristics of a human embryonic stem cell after re-plating the inner cell mass cells and before re-plating the human embryonic stem cell colony.

11. A method of isolating and maintaining a human embryonic stem cell culture, comprising the steps of:

(a) isolating cells from the inner cell mass of a blastocyst;

(b) plating the inner cell mass cells on a human feeder cell, wherein the human feeder cell is selected from the group consisting of a fetal skin fibroblast cell and a skin keloid fibroblast cell, and wherein inner cell mass-derived cell masses are formed; and

(c) re-plating and maintaining the human embryonic stem cell colony on a human feeder cell to thereby isolate and maintain a human pluripotent embryonic stem cell in an undifferentiated state for at least two passages.

12. The method of claim 11, wherein the inner cell mass-derived cells are dissociated into clusters, and re-plated on a human feeder cell, and a colony is selected with the characteristics of a human embryonic stem cell prior to re-plating the selected human embryonic stem cell colony on a human feeder cell.

13. A human pluripotent stem cell culture, comprising a human embryonic stem cell in a media comprising bFGF and a human feeder cell, wherein the human feeder cell is a bone marrow stromal cell, and wherein the human feeder cell maintains the human embryonic stem cell in an undifferentiated state for at least two passages.

14. The human pluripotent embryonic stem cell culture of claim 13, wherein the bone marrow stromal cell is ATCC deposit number CRL-11882.

15. A method of maintaining a human embryonic stem cell culture in an undifferentiated state for at least two passages, comprising culturing a human embryonic stem cell in a media comprising bFGF and on a human feeder cell layer, wherein the human feeder cell is a bone marrow stromal cell.

16. The method of claim 15, wherein the bone marrow stromal cell is ATCC deposit number CRL-11882.

17. A method of maintaining a human embryonic stem cell culture, comprising the steps of:

(a) isolating cells from the inner cell mass of a blastocyst;

(b) plating the inner cell mass cells in a media comprising bFGF, wherein inner cell mass-derived cell masses are formed; and

(c) re-plating in a media comprising bFGF and maintaining the human embryonic stem cell colony on a human feeder cell layer, wherein the human feeder cell is a bone marrow stromal cell, thereby maintaining a human embryonic stem cell in an undifferentiated state for at least two passages.

18. The method of claim 17, further comprising the step of selecting a colony with the characteristics of a human embryonic stem cell after re-plating the inner cell mass cells and before re-plating the human embryonic stem cell colony.

19. A method of isolating and maintaining a human embryonic stem cell culture, comprising the steps of:

(a) isolating cells from the inner cell mass of a blastocyst;

(b) plating the inner cell mass cells in a media comprising bEGE and on a human feeder cell, wherein the human feeder cell is a bone marrow stromal cell, and wherein inner cell mass-derived cell masses are formed; and

(c) re-plating in a media comprising bFGF and maintaining the human embryonic stem cell colony on a human feeder cell to thereby isolate and maintain a human pluripotent embryonic stem cell in an undifferentiated state for at least two passages.

20. The method of claim 19, wherein the inner cell mass-derived cells are dissociated into clusters, and re-plated on a human feeder cell, and a colony is selected with the characteristics of a human embryonic stem cell prior to re-plating the selected human embryonic stem cell colony on a human feeder cell.

21. The method of claim 20, wherein the inner cell mass-derived cells are dissociated into clusters, and re-plated on a human feeder cell, and a colony is selected with the characteristics of a human embryonic stem cell prior to re-plating the selected human embryonic stem cell colony on a human feeder cell.